dementia

FDA Will Fast-Track Decision on an Experimental and Controversial Alzheimer’s Drug

FDA Will Fast-Track Decision on an Experimental and Controversial Alzheimer’s Drug

On Friday, the pharmaceutical company Biogen announced the Food and Drug Administration accepted its application to conduct a priority review of their experimental Alzheimer’s drug for approval. The speedier-than-usual process sets the stage for the treatment, called aducanumab, to be the first new approved drug for the incurable, degenerative condition…

Study Links Serious Gum Disease to Dementia Decades Later

Study Links Serious Gum Disease to Dementia Decades Later

New research is the latest to suggest that the condition of our mouth and teeth is intimately connected to our brain health. The study found an association between people having severe gum disease or missing teeth in their early 60’s and an increased risk of them developing cognitive problems and…